Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study (Q42882546)
Jump to navigation
Jump to search
scientific article published on 20 September 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study |
scientific article published on 20 September 2010 |
Statements
1 reference
Farletuzumab, a humanized monoclonal antibody against folate receptor alpha, in epithelial ovarian cancer: a phase I study (English)
1 reference
1 reference
Lloyd J Old
1 reference
Steven M Larson
1 reference
Katherine M Bell-McGuinn
1 reference
Paul Sabbatini
1 reference
Martee L Hensley
1 reference
William P Tew
1 reference
Neeta Pandit-Taskar
1 reference
Nicholas Vander Els
1 reference
Martin D Phillips
1 reference
Charles Schweizer
1 reference
Susan C Weil
1 reference
20 September 2010
1 reference
1 reference
16
1 reference
21
1 reference
5288-5295
1 reference
Identifiers
1 reference
1 reference